Safinamide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 354 publications

Daturaolone from Datura metel L. Inhibits acetylcholinesterase and monoamine oxidase B.

Daturaolone from Datura metel L. Inhibits acetylcholinesterase and monoamine oxidase B.

Journal: Natural product research

Published: August 05, 2026

Marked Improvement of Sialorrhea with Safinamide in Parkinson's Disease: A Case Series.

Marked Improvement of Sialorrhea with Safinamide in Parkinson's Disease: A Case Series.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 24, 2026

Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review.

Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review.

Journal: Drug metabolism and personalized therapy

Published: April 23, 2026

Add-on safinamide and amantadine in Filipino Parkinson's disease patients with motor fluctuations: a retrospective exploratory cohort study.

Add-on safinamide and amantadine in Filipino Parkinson's disease patients with motor fluctuations: a retrospective exploratory cohort study.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: April 08, 2026

Pharmacological treatments of REM sleep behaviour disorder in synucleinopathies: a systematic review of effectiveness and safety.

Pharmacological treatments of REM sleep behaviour disorder in synucleinopathies: a systematic review of effectiveness and safety.

Journal: Sleep medicine

Published: April 08, 2026

Application of In Silico QSAR and Molecular Docking Studies to a Series of Xanthine-Based Analogues and Design, Synthesis and Pharmacological Evaluation of Identified New Potential Selective MAO-B Inhibitors.

Application of In Silico QSAR and Molecular Docking Studies to a Series of Xanthine-Based Analogues and Design, Synthesis and Pharmacological Evaluation of Identified New Potential Selective MAO-B Inhibitors.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 06, 2026

Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trials.

Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trials.

Journal: Journal of neurology

Published: March 23, 2026

A successful switch from rasagiline to safinamide in a 49-year-old female with early-onset Parkinson's disease: a case report and review of literature.

A successful switch from rasagiline to safinamide in a 49-year-old female with early-onset Parkinson's disease: a case report and review of literature.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 17, 2026

A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications.

A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications.

Journal: Frontiers in neurology

Published: March 12, 2026

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.

Journal: Annals of medicine

Published: March 05, 2026

In Vivo Electrochemical Monitoring of Safinamide Pharmacokinetics in the Brain Explores Its Correlation With Vision-Related Neuronal Activity.

In Vivo Electrochemical Monitoring of Safinamide Pharmacokinetics in the Brain Explores Its Correlation With Vision-Related Neuronal Activity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 29, 2026

Diplopia possibly induced by safinamide in parkinson's disease.

Diplopia possibly induced by safinamide in parkinson's disease.

Journal: Acta neurologica Belgica

Published: January 26, 2026

Showing 1-12 of 354

Last Updated: 09/26/2026